查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1820419

2025 年至 2033 年放射治療市場規模、佔有率、趨勢及預測（按類型、應用、最終用戶和地區）

Radiotherapy Market Size, Share, Trends and Forecast by Type, Application, End User, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 136 Pages | 商品交期: 2-3個工作天內

價格

2024年，全球放射治療市場規模達71億美元。展望未來， IMARC Group預測，到2033年，市場規模將達到99億美元，2025-2033年期間的複合年成長率為3.8%。目前，北美佔據市場主導地位，2024年的市佔率將超過35.8%。市場成長的因素有很多，包括癌症發病率上升、技術快速進步、腫瘤靶向準確性提高、醫療成本上升以及人們對放射治療作為一種非侵入性癌症治療替代方案的優勢的認知不斷提高。

癌症發生率的上升是放射治療市場的主要因素之一。癌症是全球日益成長的死亡原因，每年確診的病例數百萬。預計到 2024 年，美國將確診約 2,001,140 例新發癌症病例，其中 611,720 人死於癌症。這種日益成長的負擔增加了對放射治療等更好治療方案的需求。放射治療是癌症治療的關鍵組成部分，因為它可以精確地瞄準惡性細胞，同時將對健康組織的傷害降至最低。此外，老年人口的成長也加劇了這種需求，因為癌症風險隨著年齡的成長而增加。除此之外，各國政府和醫療保健組織正在啟動宣傳計劃和早期篩檢計劃，以便在可治療階段發現癌症，從而促進放射治療的使用。

美國憑藉其快速的技術進步和政府在醫療保健方面的投入，成為市場顛覆者之一。非侵入性治療方案的採用也使其脫穎而出。美國市場在尖端放射技術的實施方面處於領先地位，這極大地促進了市場的成長。近年來，質子治療設施的數量和地理不斷擴張，僅在美國就擁有超過40個營運中心，不僅提高了患者就診的可及性，也顯著提高了收集臨床資料和參與多中心臨床研究的能力。此外，美國不斷成長的醫療保健支出（預計到2023年將成長7.5%，達到4.8兆美元）是該國放射治療成長的關鍵驅動力。此外，像「癌症登月計畫」這樣的聯邦計畫致力於透過加強研究、創新和醫療服務可近性來降低癌症死亡率，這也推動了市場擴張。資金的增加促成了配備最先進放射治療系統的專科癌症中心的建立。

放射治療市場趨勢：

技術進步

放射治療產業的最新進展和技術，例如影像導引放射治療 (IGRT) 和調強放射治療 (IMRT)，提高了癌症治療的準確性和有效性，從而促進了市場的成長。 IGRT 涉及使用即時成像，以確保即使在治療期間有移動的情況下，放射治療期間也能精確瞄準腫瘤。這使醫生能夠透過調整治療期間的光束強度來調整輻射劑量，從而使輻射劑量與腫瘤形狀相匹配，同時減少對鄰近健康組織的照射。此外，國際原子能總署於 2020 年 4 月啟動了一項研究，旨在調查立體定位分次放射治療 (SFRT) 如何改善子宮頸和肺部惡性腫瘤的姑息治療，以減輕症狀並延緩病程，這有助於促進市場成長。居禮研究所擁有歐洲最全面的技術放射治療平台，是法國領先的質子治療中心。居禮研究所計劃於2023年啟動一項涵蓋廣泛的放射治療項目，其中包括一項重大投資計劃，旨在推動其技術平台的現代化，並為患者提供最具創新性和突破性的技術。這項重大計畫將在6年內投資5,600萬歐元（5,898萬美元），涵蓋所有放射治療設備以及居禮研究所在巴黎、聖克盧和奧賽的所有分支機構。

人工智慧（AI）在放射治療的應用

人工智慧技術正被用於簡化計劃流程、提高放射劑量的準確性並最佳化治療方案。機器學習 (ML) 演算法可以分析海量影像和治療記錄資料集，從而識別模式並預測針對個別患者的最佳治療方法。人工智慧也被用於開發患者對各種放射療法反應的預測模型，該模型可用於自適應放射治療，根據患者對持續治療的反應調整治療方案。放射科醫生在 40 年內需要查看約 225,000 張 MRI/CT 檢查結果，而人工智慧可以從 225,000 張掃描結果開始進行自我訓練，並在很短的時間內完成數百萬張掃描結果。這將簡化操作流程，並將醫療保健服務擴展到更廣泛的人群，從而提昇放射治療市場的收入。

轉向個人化醫療

癌症治療中個人化醫療的日益興起也對放射治療市場產生了重大影響。根據可能影響治療反應的遺傳、表現型和環境因素客製化放射劑量和時間表是個人化醫療方法的一部分，旨在根據每位患者的獨特特徵量身定做醫療方案。透過專注於量身定做的患者護理，醫療保健從業者可以提高治療效果並減少不良副作用的發生。根據個人化醫療聯盟的一項調查，2016 年至 2020 年間，美國市場上的定製藥物數量有所增加。這些藥物從 132 種增加到 2019 年的 286 種，佔 FDA 批准的所有新藥的 25%。這比 2005 年的 5% 大幅成長。這種成長正在推高放射治療市場佔有率。

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 二手資料
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

第5章：全球放射治療市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場細分：依類型

  • 體外放射治療
    • 關鍵部分
      • 調強放射治療（IMRT）
      • 影像導引放射治療（IGRT）
      • 斷層治療
      • 立體定位放射外科
      • 立體定位放射治療
      • 質子治療
      • 3D適形放射治療（3D CRT）
      • 容積調強弧形治療 (VMAT)
  • 內部放射治療/近距離放射治療
  • 全身放射治療

第7章：市場區隔：依應用

  • 皮膚和唇癌
  • 頭頸癌
  • 乳癌
  • 攝護腺癌
  • 子宮頸癌
  • 肺癌
  • 其他

第 8 章：市場區隔：依最終用戶

  • 醫院
  • 癌症研究機構
  • 門診及放射治療中心

第9章：市場細分：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第 10 章：SWOT 分析

第 11 章：價值鏈分析

第 12 章：波特五力分析

第13章：價格分析

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Accuray Incorporated
    • Becton Dickinson and Company
    • Eckert & Ziegler
    • Elekta AB (publ)
    • General Electric Company
    • Hitachi Ltd
    • Ion Beam Applications
    • Isoray Inc.
    • Mevion Medical Systems Inc.
    • Nordion Inc. (Sotera Health)
    • Siemens Healthineers AG (Siemens AG)
Product Code: SR112025A4413

The global radiotherapy market size was valued at USD 7.1 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 9.9 Billion by 2033, exhibiting a CAGR of 3.8% during 2025-2033. North America currently dominates the market, holding a market share of over 35.8% in 2024. The market is growing due to a variety of factors, including rising cancer incidence, rapid technological improvements, improved tumor targeting accuracy, rising healthcare costs, and increased awareness of the advantages of radiotherapy as a non-invasive cancer treatment alternative.

The growing incidence of cancer is one of the primary factors of the radiotherapy market. Cancer is a growing cause of mortality worldwide, with millions of cases diagnosed each year. It is expected that in 2024, there would be around 2,001,140 new instances of cancer diagnosed in the United States, with 611,720 individuals dying from the same. This growing load raises the need for better treatment options such as radiotherapy. It is a key component of cancer treatment because it can precisely target malignant cells while inflicting minimum harm to healthy tissues. Additionally, the expanding geriatric population contributes to this need, as the risk of cancer grows with age. Aside from this, governments and health care organizations are launching awareness programs and early screening initiatives to detect cancer at treatable stages, which is promoting the use of radiotherapy.

The United States is one market disruptor because of rapid technological advancement, and government expenditure on healthcare. The adoption of non-invasive treatment options also sets it apart. The US market is at the forefront of implementing cutting-edge radiation technology, which has greatly boosted the market growth. Recently, the numerical and geographic expansion of proton treatment facilities, with over 40 operating centers in the United States alone, has resulted in enhanced patient access as well as an exponential increase in the capacity to collect clinical data and complete participation in multicenter clinical studies. Furthermore, the growing healthcare expenditure in the United States, which is expected to expand 7.5% to $4.8 trillion by 2023, is a key driver of radiotherapy growth in the country. Moreover, federal programs like the Cancer Moonshot initiative that work to reduce cancer mortality rates through enhanced research, innovation, and access to care is fueling the market expansion. This increased funding has led to the establishment of specialized cancer centers equipped with state-of-the-art radiotherapy systems.

Radiotherapy Market Trends:

Technological Advancements

Recent advancements and technologies in the radiotherapy industry, such image-guided radiotherapy (IGRT) and intensity-modulated radiotherapy (IMRT), have increased the accuracy and efficacy of cancer treatments, which has aided in the market growth. IGRT involves the use of real-time imaging in order to ensure that the tumor is precisely targeted during radiation therapy sessions even in cases when there is movement between treatments. This enables doctors to adjust the radiation dosage by adjusting the beam intensity during therapy, thereby fitting the radiation dose to the shape of the tumor while reducing exposure to adjacent healthy tissues. Additionally, the IAEA launched a research in April 2020 to investigate how Stereotactic Fractionated Radiotherapy (SFRT) might improve palliative care for cervical and lung malignancies with the goal of reducing symptoms and delaying the course of the disease, which is assisting in boosting the market growth. With Europe's most comprehensive technical radiotherapy platform, Institut Curie is France's leading proton therapy center. In 2023, Institut Curie planned to launch a broad-ranging radiotherapy program involving a major investment plan to boost the modernization of its technical platform and offer its patients the most innovative and groundbreaking techniques. This major plan involves 56 million euros (USD 58.98 Million) invested over 6 years, covering all radiotherapy equipment and all Institut Curie sites: Paris, Saint-Cloud and Orsay.

Integration of Artificial Intelligence (AI) in Radiotherapy

AI technologies are being used to streamline the planning process, improve the accuracy of radiation dosing, and optimize treatment schedules. Machine learning (ML) algorithms can analyse large datasets of imaging and treatment records to identify patterns and predict optimal treatment approaches tailored to individual patients. AI is also being utilized to develop predictive models for patient responses to various radiation therapies, which can be used in adaptive radiotherapy to adjust treatments based on the patient's response to ongoing sessions. Radiologists look at approximately 225,000 MRI/CT exams in 40 years, while AI can start with 225,000 scans to train itself and reach millions of scans within a very short period of time. This will streamline operations and expand healthcare services to a larger population, thereby boosting radiotherapy market revenue.

Shift Toward Personalized Medicine

The market for radiotherapy is also majorly impacted by the increasing movement toward individualized medicine in cancer treatment. Customizing radiation doses and schedules based on genetic, phenotypic, and environmental factors that may impact treatment response is a component of personalized medicine approaches, which aim to tailor medical treatment to each patient's unique characteristics. By focusing on tailored patient care, healthcare practitioners can boost treatment efficacy and decrease the occurrence of adverse side effects. According to a survey by the Personalized Medicine Coalition, the number of customized medications available in the US market grew between 2016 and 2020. These medications increased from 132 to 286 in 2019, making up 25% of all new pharmaceuticals authorized by the FDA. This is a substantial increase from 5% in 2005. This growth is boosting the radiotherapy market share.

Radiotherapy Industry Segmentation:

Analysis by Type:

  • External Beam Radiation Therapy
    • Intensity-Modulated Radiation Therapy (IMRT)
    • Image-Guided Radiation Therapy (IGRT)
    • Tomotherapy
    • Stereotactic Radiosurgery
    • Stereotactic Body Radiation Therapy
    • Proton Therapy
    • 3D Conformal Radiotherapy (3D CRT)
    • Volumetric Modulated Arc Therapy (VMAT)
  • Internal Radiation Therapy/Brachytherapy
  • Systemic Radiation Therapy

External beam radiation therapy leads the market with around 62.0% of market share in 2024. According to radiotherapy industry market research, the increasing demand for external beam radiation treatment (EBRT) is fueled by its adaptability and efficiency in precisely treating a variety of tumors. Accordingly, EBRT continues to be the most widely used type of radiotherapy because it can precisely target tumors with high-energy beams while causing the least amount of harm to nearby healthy tissues. Additionally, the introduction of technologically sophisticated systems such as intensity-modulated radiation therapy (IMRT), stereotactic body radiation therapy (SBRT), and three-dimensional (3D) conformal radiation therapy has greatly boosted the appeal of EBRT and created a favorable outlook for market expansion.

Analysis by Application:

  • Skin and Lip Cancer
  • Head and Neck Cancer
  • Breast Cancer
  • Prostate Cancer
  • Cervical Cancer
  • Lung Cancer
  • Others

Breast cancer lead the market with around 28.8% of market share in 2024. Radiotherapy's efficacy as a standard post-operative therapeutic strategy to prevent tumor recurrence in breast cancer represents a crucial factor driving its market demand. According to the World Health Organization (WHO), there were 2.3 million women diagnosed with breast cancer and 670,000 deaths globally in 2022. This increasing incidence of breast cancer globally necessitates effective treatment modalities, and radiotherapy is recognized for its critical role in the early and advanced stages of the disease. It is particularly effective in conserving the breast in cases of early-stage breast cancer, often used following lumpectomy to eliminate any remaining cancerous cells and significantly reduce the risk of cancer returning. Additionally, radiotherapy also helps alleviate symptoms and control tumor growth in advanced metastatic cases, which is further boosting its demand.

Analysis by End User:

  • Hospitals
  • Cancer Research Institutes
  • Ambulatory and Radiotherapy Centers

As per the radiotherapy market report, its demand in ambulatory and radiotherapy centers is driven by an increasing preference for outpatient care settings, which offer cost-efficiency, convenience, and reduced patient burden compared to in-hospital treatments. Ambulatory care centers are particularly appealing because they enable patients to receive high-quality, specialized care without the need for overnight hospital stays. Additionally, these centers can often provide services at a lower cost than traditional hospital settings due to their specialized nature and efficiency in managing specific treatments like radiotherapy. This cost-effectiveness attracts patients and healthcare payers seeking to manage expenditures. Furthermore, the proliferation of radiotherapy centers and technological advancements that make sophisticated radiotherapy equipment more compact and affordable, are propelling the market forward.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2024, North America accounted for the largest market share of over 35.8%. The demand for radiotherapy in North America is propelled by numerous factors such as well-established healthcare infrastructure, robust funding for cancer research, and the high prevalence of cancer. North America boosts some of the world's leading cancer research facilities and hospitals, which adopt and also develop cutting-edge radiotherapy technologies. In addition to this, the region benefits from substantial healthcare spending both from the public and private sectors, allowing for significant investments in advanced medical equipment and treatment modalities. Furthermore, there is a strong focus on early cancer detection and screening programs, which identify patients who can benefit from early intervention using radiotherapy, which is impelling the market growth.

Key Regional Takeaways:

United States Radiotherapy Market Analysis

In North America, the United States held a market share of over 85.00% in 2024. High cancer incidence rates and improvements in treatment technology exerted an impact on the U.S. radiotherapy market. The American Cancer Society estimates that more than 1.9 million new cases of cancer were recorded in 2023. Additionally, the national health spending is projected to rise from USD 4.8 trillion in 2023 to USD 7.7 trillion by 2032, according to the Centers for Medicare & Medicaid Services (CMS). In actuality, this highlights the pressing need for sophisticated and affordable therapies like radiotherapy. The adoption of novel radiation treatments is being further accelerated by initiatives such as the National Cancer Moonshot, which aims to double the rate of improvements in cancer research and treatment. Repute players like Varian and Elekta are introducing AI-powered radiotherapy systems, which would help improve accuracy and patient outcomes. The actual utilization of proton therapy centers saw a rise of 30% in the period between 2020 and 2023, reflecting the growing demand for specialized cancer treatments in the region.

Europe Radiotherapy Market Analysis

Europe's radiotherapy market is strewn with a mighty emphasis on cancer care and sizeable government funding for innovation in healthcare. Cancer remains the second cause of death in Europe with approximately 2.7 million new cases every year. The European Union has allocated USD 5.31 Billion to health programs under Horizon Europe for 2021-2027. Such funds are bound to nudge acceptance of advanced radiotherapy equipment. The leading nations are Germany, France, and the UK, investing significant amounts in proton therapy and stereotactic radiotherapy technologies. The acceleration in this market has been further driven by a surge in non-invasive treatments and the fulfilment of the European Medical Device Regulation (MDR). The ESTRO indicated that in 2014, there were more than 2,192 linear accelerators across 27 European countries, with a significant increase in modern linear accelerators in recent years. By 2023, more than 75% of radiation oncology centers in Europe used modern linacs and ensured better patient access to precision therapy.

Asia Pacific Radiotherapy Market Analysis

Asia Pacific is one of the fastest-growing regions in terms of radiotherapy due to incidence of cancer, improved healthcare infrastructure, and growing awareness. Government initiatives, such as India's National Cancer Grid and China's Healthy China 2030 plan, form the very basis of the increasing adoption of advanced radiotherapy equipment. The region also sees massive private investment, with Japan and South Korea always at the forefront of their own research in proton therapy. According to an industrial report, China saw a 40% increase in installations of linear accelerators from 2018 to 2023. In India, oncology centers continue to adopt brachytherapy solutions at a rapid pace. Collaborative projects, such as Elekta's training programs for radiotherapists in the region, are tackling the shortage of skilled workforce to make such treatments more widely accessible.

Latin America Radiotherapy Market Analysis

The radiotherapy market in Latin America is expanding due to rising cancer rates and efforts to improve access to healthcare in the region. Brazil and Mexico capture the largest market share, with an increasing number of radiotherapy installations in public and private hospitals. In August 2024, Elekta (a Swedish Company) received a USD 64 Million order for advanced linear accelerators and the Elekta Esprit Gamma Knife from Mexico's Hospital Angeles Health System. This reflects the country's increased efforts to improve cancer care across the nation. Medical tourism in Costa Rica and Colombia is also on the rise, and clinics have taken up state-of-the-art systems to attract international patients. Such development indicates that the region is committed to managing their carcinogenic burdens effectively.

Middle East and Africa Radiotherapy Market Analysis

The radiotherapy market in Middle East and Africa is on the growth trajectory based on government initiatives and private investments in healthcare. The International Agency for Research on Cancer (IARC) reports that the African region recorded around 1.1 Million new cancer cases in the year 2020, and the burden would continue to grow with population increase and exposure to more risk factors. The Vision 2030 initiative in Saudi Arabia and the National Cancer Strategic Framework 2022-2027 in South Africa are also promoting the adoption of radiotherapy. There is also an effort to increase access by like-minded global firms partnering with local delivery providers; a case in point is the partnership by Elekta to train radiotherapists in sub-Saharan Africa. Rising telemedicine adoption and mobile health platforms further support treatment planning and follow-ups, enhancing patient outcomes.

Competitive Landscape:

The competitive landscape is characterized by the presence of prominent radiotherapy companies who are engaged in fierce competition through technological innovation, mergers, and acquisitions, and expansion into emerging markets. They are developing advanced radiotherapy systems with enhanced precision and adaptability and leveraging their broad technological portfolios and strong global presence to enhance their market share and penetrate new geographical regions. Additionally, specialized companies are focusing on niche technologies like brachytherapy and compact proton therapy systems, respectively to offer tailored solutions that meet specific clinical needs and gain a competitive edge in the market.

The report has provided a comprehensive analysis of the competitive landscape in the radiotherapy market with detailed profiles of all major companies, including:

  • Accuray Incorporated
  • Becton Dickinson and Company
  • Eckert & Ziegler
  • Elekta AB
  • General Electric Company
  • Hitachi Ltd
  • Ion Beam Applications
  • Isoray Inc.
  • Mevion Medical Systems Inc.
  • Nordion Inc. (Sotera Health)
  • Siemens Healthineers AG (Siemens AG)

Key Questions Answered in This Report

  • 1.What is radiotherapy?
  • 2.How big is the radiotherapy market?
  • 3.What is the expected growth rate of the global radiotherapy market during 2025-2033?
  • 4.What are the key factors driving the global radiotherapy market?
  • 5.What is the leading segment of the global radiotherapy market based on the type?
  • 6.What is the leading segment of the global radiotherapy market based on application?
  • 7.What is the leading segment of the global radiotherapy market based on end user?
  • 8.What are the key regions in the global radiotherapy market?
  • 9.Who are the key players/companies in the global radiotherapy market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Radiotherapy Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 External Beam Radiation Therapy
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Intensity-Modulated Radiation Therapy (IMRT)
      • 6.1.2.2 Image-Guided Radiation Therapy (IGRT)
      • 6.1.2.3 Tomotherapy
      • 6.1.2.4 Stereotactic Radiosurgery
      • 6.1.2.5 Stereotactic Body Radiation Therapy
      • 6.1.2.6 Proton Therapy
      • 6.1.2.7 3D Conformal Radiotherapy (3D CRT)
      • 6.1.2.8 Volumetric Modulated Arc Therapy (VMAT)
    • 6.1.3 Market Forecast
  • 6.2 Internal Radiation Therapy/Brachytherapy
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Systemic Radiation Therapy
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Skin and Lip Cancer
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Head and Neck Cancer
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Breast Cancer
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Prostate Cancer
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Cervical Cancer
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Lung Cancer
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Others
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Cancer Research Institutes
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Ambulatory and Radiotherapy Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Accuray Incorporated
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Becton Dickinson and Company
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Eckert & Ziegler
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 Elekta AB (publ)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 General Electric Company
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Hitachi Ltd
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Ion Beam Applications
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Isoray Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Mevion Medical Systems Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Nordion Inc. (Sotera Health)
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 SWOT Analysis
    • 14.3.11 Siemens Healthineers AG (Siemens AG)
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Radiotherapy Market: Major Drivers and Challenges
  • Figure 2: Global: Radiotherapy Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Radiotherapy Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Radiotherapy Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Radiotherapy Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Radiotherapy Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Radiotherapy Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Radiotherapy (External Beam Radiation Therapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Radiotherapy (External Beam Radiation Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Radiotherapy (Internal Radiation Therapy/Brachytherapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Radiotherapy (Internal Radiation Therapy/Brachytherapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Radiotherapy (Systemic Radiation Therapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Radiotherapy (Systemic Radiation Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Radiotherapy (Skin and Lip Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Radiotherapy (Skin and Lip Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Radiotherapy (Head and Neck Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Radiotherapy (Head and Neck Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Radiotherapy (Breast Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Radiotherapy (Breast Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Radiotherapy (Prostate Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Radiotherapy (Prostate Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Radiotherapy (Cervical Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Radiotherapy (Cervical Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Radiotherapy (Lung Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Radiotherapy (Lung Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Radiotherapy (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Radiotherapy (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Radiotherapy (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Radiotherapy (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Radiotherapy (Cancer Research Institutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Radiotherapy (Cancer Research Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Radiotherapy (Ambulatory and Radiotherapy Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Radiotherapy (Ambulatory and Radiotherapy Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: North America: Radiotherapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: North America: Radiotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: United States: Radiotherapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: United States: Radiotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Canada: Radiotherapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Canada: Radiotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Asia-Pacific: Radiotherapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Asia-Pacific: Radiotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: China: Radiotherapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: China: Radiotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Japan: Radiotherapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Japan: Radiotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: India: Radiotherapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: India: Radiotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: South Korea: Radiotherapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: South Korea: Radiotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Australia: Radiotherapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Australia: Radiotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Indonesia: Radiotherapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Indonesia: Radiotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Others: Radiotherapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Others: Radiotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Europe: Radiotherapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Europe: Radiotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Germany: Radiotherapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Germany: Radiotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: France: Radiotherapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: France: Radiotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: United Kingdom: Radiotherapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: United Kingdom: Radiotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Italy: Radiotherapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Italy: Radiotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Spain: Radiotherapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Spain: Radiotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Russia: Radiotherapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Russia: Radiotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Others: Radiotherapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Others: Radiotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Latin America: Radiotherapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Latin America: Radiotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Brazil: Radiotherapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Brazil: Radiotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Mexico: Radiotherapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Mexico: Radiotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Others: Radiotherapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Others: Radiotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Middle East and Africa: Radiotherapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Middle East and Africa: Radiotherapy Market: Breakup by Country (in %), 2024
  • Figure 82: Middle East and Africa: Radiotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Global: Radiotherapy Industry: SWOT Analysis
  • Figure 84: Global: Radiotherapy Industry: Value Chain Analysis
  • Figure 85: Global: Radiotherapy Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Radiotherapy Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Radiotherapy Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Radiotherapy Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Radiotherapy Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Radiotherapy Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Radiotherapy Market: Competitive Structure
  • Table 7: Global: Radiotherapy Market: Key Players